Novel Health Strategies

Recognized Leader for Drug & Device Strategy

Novel Health Strategies is an award winning team of experienced professionals with expertise in healthcare strategy, research, policy, publications, health economics and outcomes research, modeling, and pricing and market access. Novel Health team has led strategy projects for majority of top 50 pharmaceutical, biotech and device companies. Novel Health has large network of internal and external stakeholders and has published several thought leading strategy perspectives.

Our Team in News

During 2011-2013 NOVEL's team was interviewed and quoted by The New York Times, Scientific American and Nature Medicine.

Our team has published over 200 studies in healthcare. These studies have been cited by hundreds of publications.

We have presented trends, views and studies at conferences, federal agency meetings and special workshops.

Nineteen Presentations at ISPOR 2013 New Orleans

NOVEL's team is presenting nineteen studies on HEOR and market access trends at the 18th Annual International ISPOR meeting in New Orleans.

Podium & Poster Presentations at HTAi 2013 Seoul, Korea

At the Health Technology Assessment HTAi Annual 2013 Meeting in Seoul, Korea, NOVEL's team was selected for podium and poster presentations.

Annual Strategy Perspective in Nature Biotechnology

Since 2007 NOVEL's team has been publishing a strategy overview on biotechnology industry trends in Nature Biotechnology. This series has been cited and quoted more than two hundred times.

Market Access & Reimbursement Strategy Seminar in Copenhagen

In 2012 NOVEL's team and leading healthcare stakeholders hosted a one-day workshop on Market Access & Reimbursement Strategy in Copenhagen (Ministry of Foreign Affairs, Denmark).